Rosalyn M. Adam
Impact in
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Urology top 0.5%
- Urological Disorders and Treatments
Papers in
-
- Angiogenesis and VEGF in Cancer 9
- Surgery 41
- Tissue Engineering and Regenerative Medicine 21
- Bladder and Urothelial Cancer Treatments 15
- Co-authors
- Michael R. Freeman (49 shared papers)Jayoung Kim (17 shared papers)Keith R. Solomon (10 shared papers)Liyan Zhuang (6 shared papers)Dolores Di Vizio (19 shared papers)Mark A. Rubin (6 shared papers)Jianqing Lin (5 shared papers)Michael Klagsbrun (7 shared papers)
- Journals
- American Journal Of Pathology (9 papers)The Journal of Urology (7 papers)Cancer Research (6 papers)PLoS ONE (6 papers)Journal of Clinical Investigation (5 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Rosalyn M. Adam
116 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 1.6k
- Urology 687
- Cell Biology 1.0k
- Sensory Systems 293
- Molecular Biology 3.3k
Countries citing papers authored by Rosalyn M. Adam
This map shows the geographic impact of Rosalyn M. Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalyn M. Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalyn M. Adam more than expected).
Fields of papers citing papers by Rosalyn M. Adam
This network shows the impact of papers produced by Rosalyn M. Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalyn M. Adam. The network helps show where Rosalyn M. Adam may publish in the future.
Co-authors
The 25 scholars most cited alongside Rosalyn M. Adam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 426 | |
| 2 | 2005 | 416 | |
| 3 | 2009 | 334 | |
| 4 | 2012 | 331 | |
| 5 | The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. | 1999 | 212 |
| 6 | 1999 | 203 | |
| 7 | 2002 | 202 | |
| 8 | 2003 | 166 | |
| 9 | 2001 | 152 | |
| 10 | 1997 | 130 | |
| 11 | 2017 | 120 | |
| 12 | 2007 | 112 | |
| 13 | 2007 | 107 | |
| 14 | 2011 | 104 | |
| 15 | 1998 | 102 | |
| 16 | 2013 | 97 | |
| 17 | 1999 | 91 | |
| 18 | 2010 | 89 | |
| 19 | 2010 | 86 | |
| 20 | 2005 | 85 |
About Rosalyn M. Adam
Rosalyn M. Adam is a scholar working on Molecular Biology, Surgery, Cell Biology, Urology and Pulmonary and Respiratory Medicine, having authored 120 papers that have together received 6.2k indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (21 papers), Urinary Bladder and Prostate Research (16 papers), Bladder and Urothelial Cancer Treatments (15 papers), Caveolin-1 and cellular processes (13 papers), Electrospun Nanofibers in Biomedical Applications (11 papers), Prostate Cancer Treatment and Research (10 papers), Angiogenesis and VEGF in Cancer (9 papers) and Urological Disorders and Treatments (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Urology (687 citations), Cell Biology (1.0k citations), Sensory Systems (293 citations) and Molecular Biology (3.3k citations). Rosalyn M. Adam has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Michael R. Freeman, Jayoung Kim, Keith R. Solomon, Liyan Zhuang, Dolores Di Vizio, Mark A. Rubin, Jianqing Lin, Michael Klagsbrun, Joshua R. Mauney and Carlos R. Estrada. Their work appears in journals such as American Journal Of Pathology, The Journal of Urology, Cancer Research, PLoS ONE and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.